Cargando…

Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis

OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian, Liao, Yan-Hui, Zhang, Jian, Yang, Zhi-Ping, Xu, Gao-Si, Zhu, Liang, Fan, Dai-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665875/
https://www.ncbi.nlm.nih.gov/pubmed/34908840
http://dx.doi.org/10.2147/TCRM.S340587
_version_ 1784614099122913280
author Lan, Tian
Liao, Yan-Hui
Zhang, Jian
Yang, Zhi-Ping
Xu, Gao-Si
Zhu, Liang
Fan, Dai-Ming
author_facet Lan, Tian
Liao, Yan-Hui
Zhang, Jian
Yang, Zhi-Ping
Xu, Gao-Si
Zhu, Liang
Fan, Dai-Ming
author_sort Lan, Tian
collection PubMed
description OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results. PARTICIPANTS: A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality. RESULTS: The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14–0.23) and 0.53 (95% CI 0.46–0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10–0.18) and 0.29 (95% CI 0.25–0.33), respectively. Comorbidities were highly prevalent in individuals with HF. CONCLUSION: Heart failure hospitalization is followed by high readmission and mortality rates.
format Online
Article
Text
id pubmed-8665875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86658752021-12-13 Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis Lan, Tian Liao, Yan-Hui Zhang, Jian Yang, Zhi-Ping Xu, Gao-Si Zhu, Liang Fan, Dai-Ming Ther Clin Risk Manag Review OBJECTIVE: The current work aimed to examine the rates of and risk factors for mortality and readmission after heart failure (HF). SETTING: A systematic search was carried out in PubMed, the Cochrane Library, and EMBASE to identify eligible reports. The random-effects model was utilized to evaluate the pooled results. PARTICIPANTS: A total of 27 studies with 515,238 participants were finally meta-analysed. The HF patients had an average age of 76.3 years, with 51% of the sample being male, in the pooled analysis. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures were 30-day and 1-year readmission rates, mortality, and risk factors for readmission and mortality. RESULTS: The effect sizes for readmission and mortality were estimated as the mean and 95% confidence interval (CI). The estimated 30-day and 1-year all-cause readmission rates were 0.19 (95% CI 0.14–0.23) and 0.53 (95% CI 0.46–0.59), respectively, while the all-cause mortality rates were 0.14 (95% CI 0.10–0.18) and 0.29 (95% CI 0.25–0.33), respectively. Comorbidities were highly prevalent in individuals with HF. CONCLUSION: Heart failure hospitalization is followed by high readmission and mortality rates. Dove 2021-12-07 /pmc/articles/PMC8665875/ /pubmed/34908840 http://dx.doi.org/10.2147/TCRM.S340587 Text en © 2021 Lan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Lan, Tian
Liao, Yan-Hui
Zhang, Jian
Yang, Zhi-Ping
Xu, Gao-Si
Zhu, Liang
Fan, Dai-Ming
Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title_full Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title_fullStr Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title_full_unstemmed Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title_short Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
title_sort mortality and readmission rates after heart failure: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665875/
https://www.ncbi.nlm.nih.gov/pubmed/34908840
http://dx.doi.org/10.2147/TCRM.S340587
work_keys_str_mv AT lantian mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT liaoyanhui mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT zhangjian mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT yangzhiping mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT xugaosi mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT zhuliang mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis
AT fandaiming mortalityandreadmissionratesafterheartfailureasystematicreviewandmetaanalysis